SCHEMBL15538503

SCHEMBL15538503

CCOC(=O)c1ccc(-c2ccc(N(Cc3ccccc3)CC3CCN(CC(C)(C)F)CC3)cc2)cc1F

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 2/20 0.45
CHRM2 P08172 1/20 0.45
CHRM5 P08912 1/20 0.45
CHRM1 P11229 1/20 0.45
CHRM3 P20309 1/20 0.45
PKM P14618 1/20 0.42
NPC1 O15118 1/20 0.39
CETP P11597 2/20 0.38
SLC6A2 P23975 2/20 0.38
SLC6A4 P31645 2/20 0.38
SLC6A3 Q01959 2/20 0.38
NPSR1 Q6W5P4 1/20 0.37
ACHE P22303 2/20 0.37
LTC4S Q16873 1/20 0.36
OPRM1 P35372 2/20 0.36
MCHR1 Q99705 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
OXTR P30559 1/20 0.35
AVPR1A P37288 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15537711 0.81 CHRM4 (0.52) CHRM4CHRM2CHRM1
SCHEMBL15539847 0.81 PKM (0.41) CHRM4CHRM2CHRM5CHRM1CHRM3
SCHEMBL15538924 0.79 CHRM2 (0.44) CHRM4CHRM2CHRM5CHRM1CHRM3
SCHEMBL15539844 0.78 SSTR5 (0.44) CHRM4CHRM2CHRM5CHRM1CHRM3
SCHEMBL15539893 0.77 ACHE (0.41) CHRM2CHRM3SLC6A2SLC6A4SLC6A3
SCHEMBL15539252 0.75 CHRM4 (0.50) CHRM4CHRM2CHRM1
SCHEMBL15538472 0.74 DYRK1A (0.41) CHRM4CHRM2CHRM5CHRM1CHRM3
SCHEMBL15537618 0.74 XDH (0.42) PKMNPC1
SCHEMBL16777099 0.74 PKM (0.40) CHRM4CHRM2CHRM5CHRM1CHRM3
SCHEMBL15537859 0.73 GPR119 (0.44) CHRM2CHRM5CHRM1CHRM3PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2858986-B1 PIPERIDINE DERIVATIVES AS GPR119 AGONISTS CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2019-10-30 EP disclosed
US-9944600-B2 Piperidine derivatives for GPR119 agonist CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2018-04-17 US disclosed
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2015-06-18 US disclosed
EP-2858986-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST Chong Kun Dang Pharmaceutical Corp. (KR) 2015-04-15 EP disclosed
WO-2013187646-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2013-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST GPR119, FFAR2, GPR84 CHRM4 669/4885CHRM2 432/4885CHRM5 729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.